In 2005, W2102 multifunctional hyperthermia machine was introduced，It added a new method for the treatment of tumor by the combination of traditional Chinese and Western medicine.Since 2008，As a member of the national collaborative group for lung cancer, bowel cancer and breast cancer, the Department of Oncology participated in the study of TCM diagnosis and treatment plan，And served as the deputy leader of the bowel cancer group of the national collaboration Group to participate in the research of TCM diagnosis and treatment plan;In 2010, the key disease lung cancer in the Department of Oncology was included in the research scope of the Clinical Research Base of Traditional Chinese Medicine in Yunnan Province.In 2013, he presided over the revision of TCM diagnosis and treatment guidelines for colorectal cancer as the lead unit;In 2013, the tumor radiofrequency ablation system was introduced，A millimeter wave treatment system was introduced in 2014，It adds a new method for the treatment of tumor by the combination of traditional Chinese and Western medicine，The level of diagnosis and treatment technology of oncology department has jumped to a new level。Over the years, the Department of Oncology has accumulated rich clinical experience in the treatment of lung cancer, stomach cancer, bowel cancer, liver cancer, breast cancer, prostate cancer, brain tumor, ovarian cancer, bladder cancer, nasopharyngeal cancer, lymphoma and other diseases，At the same time, the hospice care for patients with end-stage cancer was carried out，Good social benefits have been achieved，It has been widely recognized by the society and praised by patients and their families。It has won the title of "Advanced Department" of Yunnan College of Traditional Chinese Medicine and Yunnan Provincial Hospital of Traditional Chinese Medicine for many times。
The Department of Oncology has completed a scientific research project of the State Administration of Traditional Chinese Medicine，Yunnan provincial research projects, departmental research projects and a number of subjects within the university，Won the Third Prize of Provincial Health Science and Technology Progress twice，Participated in the National Key Basic Research Development Program (973 Program) "Basic Theoretical Research on the Scale Evaluation Method Based on the dialectical treatment of Malignant Tumors"，Presided over or participated in a number of national clinical research on new drugs。Won 2 provincial scientific research awards。He has published more than 300 papers and more than 10 monographs。It has trained more than 40 master's students at home and abroad。Seven preparations for the treatment and adjuvant therapy of cancer were developed (Heiliang granules, Hongteng Granules, Dianjinkang;Topical drugs Ketong Powder, oral collapse, encapsulation Ⅰ, Rebao Ⅰ)。